CEBIOTEX
- Biotech or pharma, therapeutic R&D
Cebiotex is a clinical-stage Biotech developing CEB-01, a novel technology delivering SN-38 locally post-surgery to eliminate residual cancer cells. Now in Phase 2 for pancreatic cancer, CEB-01 is showing promising early results and strong potential in multiple hard-to-treat adult and pediatric tumors. Open to discuss fundraising and M&A opportunities.
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}